Medication info
Crelorba Tablet 20 mg (Rosuvastatin Calcium)

Crelorba Tablet 20 mg (Rosuvastatin Calcium)

Prescription medicationTablet경구
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
국제약품(주)
Appearance
Pink circular film-coated tablet
Packaging
30 tablets (10 tablets/PTP) x 3
Approval status
Active

MFDS item code 201405754 · Approved 2014.12.04 · Insurance code 643703960

Summary

Main use
Treatment for hypercholesterolemia and reduction of cardiovascular disease risk
Who takes it
Adults · Children
Adult dose
Starting at a dose of 5 mg once daily at any time of the day, regardless of food. If necessary, the dose may be increased to 10 mg once daily at intervals of 4 weeks or longer, based on LDL cholesterol levels and treatment targets, and may be titrated up to a maximum of 20 mg once daily.
Child dose
For pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia, a dose of 5 mg to 20 mg is administered once daily. The dosage should be adjusted according to the individual treatment goals at intervals of 4 weeks or longer.

Ingredients

Manufacturer
국제약품(주)

Efficacy & effects

Treatment for hypercholesterolemia and reduction of cardiovascular disease risk

  • Hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerosis
  • dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of premature coronary heart disease
  • stroke risk
View approved original text

This medication is primarily used as an adjunct to diet and exercise when needed for patients with primary hypercholesterolemia and mixed hyperlipidemia. It is also helpful in the treatment of patients with homozygous familial hypercholesterolemia and effectively lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis. It is also utilized as an adjunct to diet in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia who meet certain criteria. It is also applied for the treatment of patients with primary dysbetalipoproteinemia and contributes to reducing cardiovascular disease risk. Specifically, it is effective in lowering the risk of stroke, myocardial infarction, and arterial revascularization. Overall, it is used to improve these factors and promote cardiovascular health.

How to take

Adult dose

Starting at a dose of 5 mg once daily at any time of the day, regardless of food. If necessary, the dose may be increased to 10 mg once daily at intervals of 4 weeks or longer, based on LDL cholesterol levels and treatment targets, and may be titrated up to a maximum of 20 mg once daily.

Child dose

For pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia, a dose of 5 mg to 20 mg is administered once daily. The dosage should be adjusted according to the individual treatment goals at intervals of 4 weeks or longer.

Precautions

This medication should not be used by individuals who are allergic to certain components. People with active liver disease or unexplained elevated liver enzyme levels should also avoid this medication. Patients with muscle disease or those taking cyclosporine, as well as individuals with severely impaired kidney function, should avoid this medication. Women who are pregnant or breastfeeding and those of childbearing age who are not using adequate contraception should refrain from using this medication. Those at high risk for myopathy or rhabdomyolysis should particularly avoid high doses (40 mg), especially if they have impaired kidney function, hypothyroidism, or family history. This medication contains lactose, thus should not be taken by individuals with lactose intolerance or related genetic disorders. Those who consume alcohol excessively or have a history of liver disease should have regular liver function tests while on this medication. If symptoms such as muscle pain or weakness occur, notify your healthcare provider immediately, and consider discontinuing use as necessary. In cases of acute severe conditions or severe renal failure, discontinue this medication immediately. Rarely, this medication may lead to severe muscle weakness or ocular myasthenia, and it should be halted immediately if symptoms occur. When combined with other specific medications, the risk of muscle-related side effects may increase, so consult with your healthcare provider regarding concomitant medications. High-dose use may lead to temporary proteinuria, which may require kidney function tests. In Asians, the drug concentration may be higher, necessitating dosage adjustments. In children and adolescents, the effects on growth and secondary sexual characteristics should be considered when deciding on use. Adverse reactions such as interstitial lung disease, severe liver damage, and severe skin reactions have been reported rarely; discontinue if unusual symptoms occur and consult a healthcare provider. This medication can interact with certain drugs, so if you are taking other medications, be sure to inform your healthcare provider and exercise caution. Women who are pregnant or planning to become pregnant should avoid this medication and use suitable contraceptive methods. In cases of overdose, there is no specific antidote, and treatment and liver and muscle function tests should be conducted based on symptoms. Caution should be exercised when driving or operating machinery as dizziness may occur. Although no specific cancer risk has been reported with long-term use of this medication, ongoing observation for adverse reactions during treatment is necessary.

Side effects and when to seek care immediately

Serious side effects

Allergic reactions including urticaria and angioedema, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, fatal and non-fatal liver failure, jaundice, hepatitis, severe myasthenia, ocular myasthenia, rhabdomyolysis, immune-mediated necrotizing myopathy, polyneuropathy, peripheral neuropathy, thrombocytopenia, edema, severe allergic reactions, severe skin reactions, respiratory distress, difficulty breathing

Mild side effects

  • Headache
  • dizziness
  • constipation
  • nausea
  • abdominal pain
  • itching
  • rash
  • myalgia
  • weakness
  • hematuria
Show 25 more
  • diarrhea
  • chest pain
  • cough
  • joint pain
  • fatigue
  • numbness
  • sensory disturbance
  • chest discomfort
  • loss of appetite
  • abdominal bloating
  • abnormal liver function tests
  • syncope
  • generalized pain
  • muscle cramps
  • gout
  • erectile dysfunction
  • depression
  • sleep disorders
  • sexual dysfunction
  • gynecomastia
  • memory impairment
  • forgetfulness
  • amnesia
  • memory disorder
  • confusion

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture, ideally at room temperature between 1 to 30 degrees Celsius. By doing so, the effectiveness of the medication can be maintained for an extended period.

Appearance and packaging

Appearance

Pink circular film-coated tablet

Package unit

30 tablets (10 tablets/PTP) x 3

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.